PL212820B1 - Method of obtaining (Z)-9,10-dihydroxy-6,10-dimethylundec-5-en-2-one and (Z)-10-hydroxy-6,10-dimethylundec-5-en-2,9-dion - Google Patents
Method of obtaining (Z)-9,10-dihydroxy-6,10-dimethylundec-5-en-2-one and (Z)-10-hydroxy-6,10-dimethylundec-5-en-2,9-dionInfo
- Publication number
- PL212820B1 PL212820B1 PL390311A PL39031110A PL212820B1 PL 212820 B1 PL212820 B1 PL 212820B1 PL 390311 A PL390311 A PL 390311A PL 39031110 A PL39031110 A PL 39031110A PL 212820 B1 PL212820 B1 PL 212820B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- dimethylundec
- dihydroxy
- dimethyloundec
- hydroxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 11
- LULGAMGLRIFCJL-POHAHGRESA-N (z)-9,10-dihydroxy-6,10-dimethylundec-5-en-2-one Chemical compound CC(=O)CC\C=C(\C)CCC(O)C(C)(C)O LULGAMGLRIFCJL-POHAHGRESA-N 0.000 title 1
- INLYNZTXPQZNPO-UHFFFAOYSA-N OC(C(CCC(=C/CCC(C)=O)C)=O)(C)C Chemical compound OC(C(CCC(=C/CCC(C)=O)C)=O)(C)C INLYNZTXPQZNPO-UHFFFAOYSA-N 0.000 title 1
- 230000009466 transformation Effects 0.000 claims description 7
- HNZUNIKWNYHEJJ-UHFFFAOYSA-N geranyl acetone Natural products CC(C)=CCCC(C)=CCCC(C)=O HNZUNIKWNYHEJJ-UHFFFAOYSA-N 0.000 claims description 6
- HNZUNIKWNYHEJJ-XFXZXTDPSA-N geranylacetone Chemical compound CC(C)=CCC\C(C)=C/CCC(C)=O HNZUNIKWNYHEJJ-XFXZXTDPSA-N 0.000 claims description 6
- 241000879295 Fusarium equiseti Species 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 241001133184 Colletotrichum agaves Species 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- -1 acyclic terpenoids Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 244000000004 fungal plant pathogen Species 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004476 plant protection product Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
Opis wynalazkuDescription of the invention
Przedmiotem wynalazku jest sposób otrzymywania (Z)-9,10-dihydroksy-6,10-dimetyloundec-5-en-2-onu, o wzorze 2, i (Z)-10-hydroksy-6,10-dimetyloundec-5-en-2,9-dionu, o wzorze 3.The present invention relates to a process for the preparation of (Z) -9,10-dihydroxy-6,10-dimethyloundec-5-en-2-one, of formula 2, and (Z) -10-hydroxy-6,10-dimethyloundec-5- en-2,9-dione of formula 3.
Wynalazek może znaleźć zastosowanie w przemyśle chemicznym, do produkcji środków ochrony roślin.The invention may find application in the chemical industry for the production of plant protection products.
Znany jest sposób otrzymywania (Z)-9,10-dihydroksy-6,10-dimetyloundec-5-en-2-onu, o wzorze 2, z neryloacetonu, o wzorze 1, na drodze mikrobiologicznej transformacji, z udziałem szczepu Glomerella cingulata (M. Miyazawa. H. Nankai, H. Kameoka, Biotransformations of acyclic terpenoids, (±)-cis-nerolidol and nerylacetone, by plant pathogenic fungus, Glomerella cingulata, Phytochemistry, 40, 1995, ss. 1133-1 137).There is known a method of obtaining (Z) -9,10-dihydroxy-6,10-dimethyloundec-5-en-2-one, of the formula 2, from nerylacetone, of the formula 1, by means of microbiological transformation with the participation of the Glomerella cingulata strain ( M. Miyazawa, H. Nankai, H. Kameoka, Biotransformations of acyclic terpenoids, (±) -cis-nerolidol and nerylacetone, by plant pathogenic fungus, Glomerella cingulata, Phytochemistry, 40, 1995, pp. 1133-1 137).
W dostę pnej literaturze nie znaleziono publikacji o otrzymywaniu (Z)-9,10-dihydroksy-6,10-dimetyloundec-5-en-2-onu i (Z)-10-hydroksy-6,10-dimetyloundec-5-en-2,9-dionu z neryloacetonu, na drodze biotransformacji z udziałem szczepu Fusarium equiseti.No publications were found in the available literature on the preparation of (Z) -9,10-dihydroxy-6,10-dimethyloundec-5-en-2-one and (Z) -10-hydroxy-6,10-dimethyloundec-5-ene -2,9-dione from nerylacetone, by biotransformation involving the Fusarium equiseti strain.
Istota wynalazku polega na tym, że transformację prowadzi się za pomocą systemu enzymatycznego szczepu grzyba Fusarium equiseti.The essence of the invention lies in the fact that the transformation is carried out with the enzyme system of the Fusarium equiseti fungus strain.
Korzystnie jest, gdy procesy prowadzi się wodną kulturą szczepu, przy ciągłym mieszaniu reagentów, w temperaturze 291-303 K.It is advantageous if the processes are carried out in an aqueous strain, with continuous mixing of the reactants, at a temperature of 291-303 K.
Postępując zgodnie z wynalazkiem, w wyniku działania układu enzymatycznego, zawartego w komórkach grzyba Fusarium equiseti, z neryloacetonu, o wzorze 1, otrzymuje się (Z)-9,10-dihydroksy-6,10-dimetyloundec-5-en-2-on, o wzorze 2 i (Z)-10-hydroksy-6,10-dimetyloundec-5-en-2,9-dion, o wzorze 3.Following the invention, the action of the enzyme system contained in the cells of the fungus Fusarium equiseti gives (Z) -9,10-dihydroxy-6,10-dimethyloundec-5-en-2-one from nerylacetone of formula 1 , of formula 2 and (Z) -10-hydroxy-6,10-dimethyloundec-5-ene-2,9-dione of formula 3.
Uzyskane w ten sposób produkty, wydziela się z wodnej kultury mikroorganizmu, przez ekstrakcję chlorkiem metylenu.The products obtained in this way are separated from the water culture of the microorganism by extraction with methylene chloride.
Zasadniczą zaletą metody wytwarzania wspomnianych związków jest to, że otrzymuje się je w ł agodnych warunkach, z wydajnoś cią odpowiednio 13% i 26%.The main advantage of the method of producing said compounds is that they are obtained under mild conditions with a yield of 13% and 26%, respectively.
Wynalazek jest bliżej objaśniony w przykładzie wykonania.The invention is explained in more detail in an exemplary embodiment.
P r z y k ł a d. Do 16 kolb Erlenmayera o pojemności 300 cm3, w których znajduje się po 100 cm3 sterylnej pożywki, zawierającej: 3 g glukozy i 1 g aminobaku, wprowadza się szczep Fusarium equiseti. Po czterech dniach wzrostu dodaje się 160 mg neryloacetonu, o wzorze 1 (10 mg/100 cm3 pożywki), rozpuszczonego w 16 cm3 acetonu. Transformację prowadzi się, w temperaturze około 295 K, przy ciągłym wstrząsaniu, przez 6 dni. Następnie roztwór potransformacyjny ekstrahuje się trzykrotnie chlorkiem metylenu, ekstrakt suszy bezwodnym siarczanem magnezu i odparowuje rozpuszczalnik. Otrzymaną mieszaninę produktów: (Z)-9,10-dihydroksy-6,10-dimetyloundec-5-en-2-onu, o wzorze 2 i (Z)-10-hydroksy-6,10-dimetyloundec-5-en-2,9-dionu, o wzorze 3, wraz z metabolitami szczepu grzyba, oczyszcza się chromatograficznie na żelu krzemionkowym, używając jako eluentu mieszaniny heksan:aceton, w stosunku objętościowym 2:1. Na tej drodze otrzymuje się 25 mg (wydajność 13%) (Z)-9,10-dihydroksy-6,10-dimetyloundec-5-en-2-onu, o wzorze 2 oraz 48 mg (wydajność 26%) (Z)-10-hydroksy-6,10-dimetyloundec-5-en-2,9-dionu, o wzorze 3.EXAMPLE Fusarium equiseti strain is introduced into 16 Erlenmayer flasks with a capacity of 300 cm 3 , each containing 100 cm 3 of sterile medium containing: 3 g of glucose and 1 g of aminobac. After four days of growth, 160 mg of nerylacetone of formula 1 (10 mg / 100 cm 3 of medium) dissolved in 16 cm 3 of acetone are added. The transformation is carried out at about 295 K under continuous shaking for 6 days. Then the post-transformation solution was extracted three times with methylene chloride, the extract was dried with anhydrous magnesium sulfate and the solvent was evaporated. The resulting mixture of products: (Z) -9,10-dihydroxy-6,10-dimethyloundec-5-en-2-one, of formula 2 and (Z) -10-hydroxy-6.10-dimethyloundec-5-en- The 2,9-dione of formula III, together with the fungal strain metabolites, was purified by chromatography on silica gel using a 2: 1 v / v hexane: acetone mixture as eluent. In this way, 25 mg (13% yield) of (Z) -9,10-dihydroxy-6,10-dimethyloundec-5-en-2-one of formula 2 and 48 mg (26% yield) are obtained (Z) -10-hydroxy-6,10-dimethyloundec-5-ene-2,9-dione of formula 3.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL390311A PL212820B1 (en) | 2010-01-29 | 2010-01-29 | Method of obtaining (Z)-9,10-dihydroxy-6,10-dimethylundec-5-en-2-one and (Z)-10-hydroxy-6,10-dimethylundec-5-en-2,9-dion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL390311A PL212820B1 (en) | 2010-01-29 | 2010-01-29 | Method of obtaining (Z)-9,10-dihydroxy-6,10-dimethylundec-5-en-2-one and (Z)-10-hydroxy-6,10-dimethylundec-5-en-2,9-dion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL390311A1 PL390311A1 (en) | 2010-07-19 |
| PL212820B1 true PL212820B1 (en) | 2012-11-30 |
Family
ID=42370742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL390311A PL212820B1 (en) | 2010-01-29 | 2010-01-29 | Method of obtaining (Z)-9,10-dihydroxy-6,10-dimethylundec-5-en-2-one and (Z)-10-hydroxy-6,10-dimethylundec-5-en-2,9-dion |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL212820B1 (en) |
-
2010
- 2010-01-29 PL PL390311A patent/PL212820B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL390311A1 (en) | 2010-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101245057A (en) | A kind of preparation method of glucal | |
| PL212820B1 (en) | Method of obtaining (Z)-9,10-dihydroxy-6,10-dimethylundec-5-en-2-one and (Z)-10-hydroxy-6,10-dimethylundec-5-en-2,9-dion | |
| de Melo Souza et al. | One step N-glycosylation by filamentous fungi biofilm in bioreactor of a new phosphodiesterase-3 inhibitor tetrazole | |
| PL212819B1 (en) | Method of manufacturing (Z)-9,10-dihydroxy-6,10-dimethylundec-5-en-2-one and (Z)-10-hydroxy-6,10-dimethylundec-5-en-2,9-dion | |
| CN100457770C (en) | Process of refining calcium dibutyryl adenosine cyclophosphate | |
| KR102672024B1 (en) | Manufacturing method of durumamide A | |
| PL212822B1 (en) | Method of obtaining (Z)-3,7,11-trimethyldodeca-1,6-dien-3,10,11-triol and (Z)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-one | |
| PL212821B1 (en) | Method of manufacturing (Z)-3,7,11-trimethyldodeca-1,6-dien-3,10,11-triol and (Z)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-one | |
| PL234085B1 (en) | 4'-O-β-D-glucopyranosyl-4,2'-dihydroxy-3'-[3"-methylbutyl]-6'-methoxy-α,β-dihydrochalcone and method for obtaining 4'-O-β-D-glucopyranosyl-4,2'-dihydroxy-3'-[3"-methylbutyl]-6'-methoxy-α,β-dihydrochalcone | |
| CN103451242A (en) | Method for preparing 1alpha-hydroxy vitamin D through microbial conversion | |
| PL208574B1 (en) | Method for obtaining of (4S,5S)-5-(4'-methyl-3'-pentenyl)-4-hydroxy-5-methyldihydrofuran-2-one | |
| PL207817B1 (en) | Method for the manufacture of S-(-)-6-chloro-1, 2, 3, 4-tetrahydro-2-naphtol | |
| PL223446B1 (en) | 4'-O-β-D-glucopyranosylxanthohumol C and a method for its manufacturing | |
| PL207816B1 (en) | Method for the manufacture of S-(-)-7-methoxy-1, 2, 3, 4-tetrahydro-2-naphtol | |
| PL207821B1 (en) | Method for the manufacture of S-(-)-8-methoxy-1, 2, 3, 4-tetrahydro-2-naphtol | |
| PL221629B1 (en) | Process for preparing 4-hydroxydihydrojasmone of antifidant activity | |
| CN111518116A (en) | Preparation method of hydroxymethyl clopidogrel impurity | |
| PL223444B1 (en) | Method for preparing 1",2",α,β-tetrahydroxanthohumol C | |
| PL207815B1 (en) | Method for the manufacture of S-(-)-6-methoxy-1, 2, 3, 4-tetrahydro-2-naphtol | |
| PL178581B1 (en) | Method for the production of 12β, 15a-dihydroxy-4-androsten-3-one | |
| PL211932B1 (en) | Method for production of (4S,5S)-5-(4'-methyl-3'-pentenyl)-4-hydroxy-5-methyldihydrofuran-2-one | |
| PL215792B1 (en) | (Z)-6-sulfate-6,4'-dihydroxy-7-prenyl-4-metoksyaurone and process for the preparation thereof | |
| PL235716B1 (en) | 4-Ethyl-4'methyl-α,β-dihydrochalcone and method for obtaining 4-ethyl-4'methyl-α,β-dihydrochalcone | |
| PL221644B1 (en) | Method for preparing (+) -5 - (1-hydroxy-3-methylbutyl) -4,4-dimethyltetrahydrofuran-2-one | |
| PL210282B1 (en) | New (4aR,7R)-(-)-4,4a,5,6,7,8-hexahydro-7ß-hydroxyl-4a-methyl-2-(3H)-naphtalenone and method for its manufacture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LICE | Declarations of willingness to grant licence |
Effective date: 20120720 |
|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20130129 |